Peter Lembessis

ORCID: 0000-0001-8972-3499 · 4 papers in corpus · active 2001-2004

Study types

  • article 4

Condition tags

  • endometriosis 4
article 2004
Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells.
In vivo (Athens, Greece)

We analysed the glucocorticoid receptor (GR) regulation on the expression of insulin-like growth factor 1 (IGF-1), type I IGF receptor (IGF-1.R), IGF-binding protein 3 (IGFBP-3), urokinase-type plasminogen activator (uPA) and uPA receptor (…

article 2003
Mutation analysis of BrCA1, BrCA2, and p53 versus soluble HLA class I and class II in a case of familial endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(02)04665-4
article 2003
Urokinase‐Type Plasminogen Activator and Insulin‐Like Growth Factor‐Binding Protein 3 mRNA Expression in Endometriotic Lesions and Eutopic Endometrium
Annals of the New York Academy of Sciences ·doi:10.1196/annals.1290.025

The peritoneal fluid of women with endometriosis contains an increased insulin-like growth factor 1 (IGF-1) bioavailability, which is produced by limited hydrolysis of urokinase-type plasminogen activator (uPA) on IGF-binding protein 3 (IGF…

article 2001
Increased Insulin-like Growth Factor 1 Activity Can Rescue KLE Endometrial-like Cells from Apoptosis
Molecular medicine (Cambridge, Mass.) ·doi:10.1007/bf03401835

BACKGROUND: The peritoneal fluid (PF) of women with endometriosis contains protease(s) activity able to hydrolyze insulin-like growth factor-binding protein 3 (IGFBP-3), increasing the bioavailability of insulin-like growth factor-1 (IGF-1)…